Ipamorelin is a selective GH secretagogue that triggers clean GH pulses without raising cortisol, prolactin, or appetite
Improved patient care that streamlines medication processing for patients
BrownAJGoldsworthySMBarnesAAEilertMMTcheangLDanielsDet al
A separate Phase 2 trial also published in The New England Journal of Medicine in 2023 evaluated retatrutide in adults with type 2 diabetes, reporting meaningful reductions in HbA1c alongside weight loss, with hypoglycaemia rates that were low in the absence of insulin or sulfonylurea co-administration
Cardiometabolic improvements across published trials include reductions in blood pressure, triglycerides, LDL-cholesterol, HbA1c, and fasting glucose
Together, this evidence suggests that GIP may drive WL directly, inhibiting caloric intake, indirectly exploiting the anorectic action of GLP-1, or by reducing GLP-1RA adverse effects (59, 60, 63)